VanEck Pharmaceutical ETF Rating → The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad) Free PPH Stock Alerts $91.93 -0.11 (-0.12%) (As of 06/13/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy2.64Holdings in PPH have an aggregate rating of Moderate Buy based on 222 analyst ratings issued in the past year covering 23 companies (90.9% of the portfolio).PPH Aggregate Price Target$99.508.23% UpsideHigh Prediction$117.28Average Prediction$99.50Low Prediction$81.97Holdings in PPH have an aggregate price target of $99.50 and a range of $81.97 to $117.28 covering 23 companies (90.9% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 PPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.47%LLYEli Lilly and Company$882.21+1.7%4 of 5 stars2.84$787.53 -10.7%19Analyst ForecastInsider Selling10.30%NVONovo Nordisk A/S$142.49-0.5%1 of 5 stars2.78$145.67 2.2%9Analyst ForecastShort Interest ↑6.08%JNJJohnson & Johnson$145.400.0%5 of 5 stars2.38$174.07 19.7%13Analyst DowngradeShort Interest ↑Analyst Revision6.07%MRKMerck & Co., Inc.$129.36-0.6%4 of 5 stars2.69$133.00 2.8%13Positive News6.04%AZNAstraZeneca$79.53-0.7%3 of 5 stars2.67$88.00 10.7%9Short Interest ↓Positive News5.53%ABBVAbbVie$166.59+0.3%5 of 5 stars2.86$178.21 7.0%144.90%MCKMcKesson$591.05+1.1%5 of 5 stars2.87$571.47 -3.3%15Insider SellingNews Coverage4.65%PFEPfizer$27.650.0%5 of 5 stars2.40$35.86 29.7%154.56%SNYSanofi$47.53-1.9%2 of 5 stars2.40$55.00 15.7%5Short Interest ↑Positive NewsGap Down4.52%HLNHaleon$8.49+1.9%3 of 5 stars2.805News CoveragePositive News4.42%CORCencora$232.23+0.9%4 of 5 stars2.67$233.90 0.7%9Positive News4.28%GSKGSK$41.100.0%3 of 5 stars2.33$47.00 14.4%6Short Interest ↓4.23%ZTSZoetis$171.25-2.6%5 of 5 stars3.00$211.75 23.6%7Positive News3.36%BMYBristol-Myers Squibb$41.46-2.2%5 of 5 stars2.11$60.00 44.7%193.24%TEVATeva Pharmaceutical Industries$17.40+1.0%1 of 5 stars2.75$15.88 -8.7%8Short Interest ↑1.59%VTRSViatris$10.39-2.3%1 of 5 stars1.33$11.00 5.9%31.04%ELANElanco Animal Health$18.11+1.3%3 of 5 stars2.57$18.29 1.0%7Positive News0.95%JAZZJazz Pharmaceuticals$112.70+1.5%5 of 5 stars2.86$190.92 69.4%14Positive News0.91%CTLTCatalent$55.97+0.0%2 of 5 stars2.17$53.14 -5.1%12Positive News0.63%OGNOrganon & Co.$20.52-1.5%5 of 5 stars2.50$22.60 10.2%4Positive News0.53%PRGOPerrigo$27.38-1.7%5 of 5 stars3.00$39.67 44.9%3Analyst Forecast0.32%BHCBausch Health Companies$6.17-2.2%4 of 5 stars2.25$11.33 83.7%4Short Interest ↓Positive News0.27%PDCOPatterson Companies$22.88+0.1%4 of 5 stars2.33$31.67 38.4%9Upcoming EarningsDividend Announcement This page (NASDAQ:PPH) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.